Physician profile
Amanda E Ast
NPI 1255834735
$9,001.82
in general payments reported to CMS, 2019-2025
35 companies · $3,543 in 2025
The $3,543 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $634 · 2022: $1,459 · 2023: $1,415 · 2024: $1,952 · 2025: $3,543.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,482 · Travel and Lodging: $1,402 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,481.72 |
| Travel and Lodging | $1,402.11 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $2,179.47 | 2021-2025 | Omnipod, Omnipod |
| Lilly USA, LLC | $1,088.46 | 2021-2025 | Mounjaro, Zepbound, Humulin |
| Dexcom, INC. | $744.05 | 2021-2025 | Dexcom G6 Transmitter |
| Abbott Laboratories | $725.34 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Senseonics, Incorporated | $640.00 | 2022 | |
| Novo Nordisk INC | $638.75 | 2021-2025 | Rybelsus, Ozempic, Sogroya |
| Sanofi-Aventis U.S. LLC | $529.01 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $416.96 | 2023-2025 | |
| Corcept Therapeutics | $299.56 | 2024-2025 | Korlym |
| Xeris Pharmaceuticals, INC. | $238.11 | 2021-2025 | Gvoke Hypopen, Recorlev |
| Amgen INC. | $167.03 | 2024-2025 | Evenity, Prolia, Prolia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $162.01 | 2022-2025 | Jardiance |
| Recordati_rare_diseases_inc. | $149.29 | 2023-2024 | Signifor Lar, Isturisa |
| Astrazeneca Pharmaceuticals Lp | $145.46 | 2021-2025 | Farxiga |
| Abbvie INC. | $134.75 | 2023-2025 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $109.26 | 2023-2024 | |
| Ascensia Diabetes Care US INC. | $84.50 | 2022-2023 | |
| Beta Bionics, INC. | $70.14 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Sequel Med Tech, LLC | $58.45 | 2025 | Twiist |
| Radius Health, INC. | $57.07 | 2023-2025 | Tymlos |
| Currax Pharmaceuticals LLC | $56.57 | 2023-2025 | Contrave, Nexletol |
| Nevro Corp. | $44.39 | 2022-2023 | Senza |
| Amarin Pharma, INC. | $29.09 | 2021 | |
| Averitas Pharma INC. | $28.55 | 2023 | Qutenza |
| Medtronic, INC. | $26.88 | 2025 | Minimed 780g |
| Neurocrine Biosciences, INC. | $23.01 | 2025 | |
| Chiesi USA, INC. | $21.72 | 2025 | Myalept |
| Recor Medical INC | $21.56 | 2025 | Paradise Ultrasound Renal Denervation System |
| Zealand Pharma US, INC. | $20.22 | 2022 | |
| Amryt Pharma Holdings Ltd | $17.57 | 2023 | Myalept |
| Tandem Diabetes Care, INC. | $16.69 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Kyowa Kirin, INC. | $16.64 | 2023 | |
| Embecta Corp. | $15.07 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Merck Sharp & Dohme LLC | $13.27 | 2021 | |
| Amneal Pharmaceuticals LLC | $12.92 | 2023 | Unithroid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Ast listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.